Pulse Biosciences Inc (FRA:6L8)
€ 16.5 -0.2 (-1.2%) Market Cap: 1.13 Bil Enterprise Value: 1.07 Bil PE Ratio: 0 PB Ratio: 13.98 GF Score: 40/100

Q4 2020 Pulse Biosciences Inc Earnings Call Transcript

Feb 22, 2021 / 09:30PM GMT
Release Date Price: €28.25 (+2.13%)
Operator

Greetings, and welcome to Pulse Biosciences Fourth Quarter 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn this conference over to your host, Mr. Philip Taylor, Investor Relations. Please go ahead. You may begin.

Philip Taylor
Gilmartin Group LLC - Associate

Thank you, operator. Before we begin, I would like to inform you that comments and responses to your questions during today's call reflect management's views as of today, February 22, 2021, only and will include forward-looking statements and opinion statements. These statements regarding our plans and expectations relating to regulatory clearance, including the process, time lines and expected outcomes; our commercial, operational, scientific, clinical and financial projections; products, including the uses, benefit and applications of such products; our commercial and regulatory strategies; the impact of the COVID-19 pandemic; and other future events.

Actual results may differ materially from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot